INDEPENDENT ANTI-DOPING REFERENCE2026 · CHECKED 08 NOV 2027 PUBLISHED ↗
WADAFUK!?
Source-checked educational research

Levmetamfetamine.

S6
Source-checked educational research

Checked 2026-11-10. Independent clinical review has not been completed. WADAFUK is independent of WADA and does not provide medical advice or an individual anti-doping determination.

REGULATORY SUMMARY2026 LIST

Prohibited in competition

WADA 2026: S6.B, specified, prohibited in competition. The future 2027 List retains this classification. [1] [2]

2026 and 2027 List, S6.B, printed pp.15–16; introductory definitions p.3 · 2026 rules apply from 1 January 2026. Any 2027 material below concerns future rules from 1 January 2027; it is not current clearance.

EVIDENCE / 01

Isomer distinction

The List places d-methamphetamine in S6.A and levmetamfetamine in S6.B. Both are prohibited in competition; their specified classifications differ. Optical-isomer coverage must not be turned into automatic sanction advice. [1] [2]

EVIDENCE / 02

Nasal-product exposure

A US DailyMed OTC inhaler label identifies levmetamfetamine as a nasal decongestant for temporary congestion. It warns about local irritation and recurrent or worsening congestion with prolonged use. OTC presentation does not supply a WADA exception. [3]

Limits of this evidence
  • The product label is not a dosing guide for sport.

What remains uncertain

  • Educational synthesis only; not individualized medical advice, a TUE decision or a sanction prediction.
TRACEABILITY

Check the sources.

These are concise editorial paraphrases of selected sources, not a systematic review or a reproduction of source tables. Access depth is shown for each reference; an abstract-only check cannot resolve details found only in a full paper.

  1. WADA 2026 Prohibited List ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected

    Introduction p.3 · S6 pp.15–16

  2. WADA 2027 Prohibited List, 4 November revision ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected · FUTURE 2027 SOURCE

    Introduction p.3 · S6 pp.15–16

  3. M14. DailyMed. Levmetamfetamine nasal inhalant label. ↗Accessed 2026-11-10 · relevant full-text sections independently opened and inspected

    Active ingredient, use and warnings

Before acting on this information

Check the current official WADA List and the relevant anti-doping authority for your sport, product, route and circumstances. Do not stop or change necessary treatment based on this page. Ask a qualified clinician about health decisions. Missing evidence does not establish safety.

Something wrong? Prepare a correction draft ↗